1,4,10-Trioxa-7,13-diazacyclopentadecane,
31249-95-3,
1,4,10-Trioxa-7,13-diaza-cyclopentadecane,
cryptand 21,
4,10-Diaza-15-crown 5-Ether,
Kryptofix 21,
EINECS 250-530-3,
1,7-diaza-15-crown-5,
STHIZMRUXPMSCW-UHFFFAOYSA-N,
C10H22N2O3,
1,7,13-Trioxa-4,10-diazacyclopentadecane,
4,7,13-Trioxa-1,10-diazacyclopentadecane,
NSC339327,
Kryptofix® 21,
AC1L3WKY,
ACMC-1CRE7,
AC1Q70EA,
Oprea1_439104,
SCHEMBL27350,
MLS000556245,
CHEMBL1408686,
CTK1C4014,
DTXSID90185173,
HMS2316B14,
BB_SC-00079,
ZINC3882163,
ANW-41462,
BBL012316,
MFCD00005109,
STK803170,
AKOS001579675,
MCULE-5924339080,
NSC-339327,
ACM31249953,
NCGC00246473-01,
CC-03212,
SMR000147562,
1,7,10-Trioxa-4,13-diazacyclopentadecane,
LS-157638,
TR-013294,
D2744,
EU-0034168,
FT-0754072,
ST50307196,
Z2265,
C-34126,
1,4,10-Trioxa-7,13-diaza-cyclopentadecane, 97%,
J-018294,
I14-18761,
C1COCCNCCOCCOCCN1,
AR-1I2746,
CID123435,
C10-H22-N2-O3,
32586-76-8,